Actinium Pharmaceuticals (ATNM) Q2 2024 Earnings
ATNM·Reported August 5, 2024·Before market open
Diluted EPS came in at $-0.38, beat the $-0.48 consensus by $0.10.
Diluted EPS
$-0.38beat by $0.10
Consensus: $-0.48
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Actinium Pharmaceuticals's Q2 2024 earnings report.
Actinium Pharmaceuticals (ATNM) reported Q2 2024 earnings on August 5, 2024 before market open.
Actinium Pharmaceuticals reported diluted EPS of $-0.38 for Q2 2024.
EPS beat the consensus estimate of $-0.48 by $0.10.
You can read the 10-Q periodic report (0001213900-24-065239) directly on SEC EDGAR. The filing index links above go to sec.gov.